By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS








Company News
Agios Pharmaceuticals (AGIO) Announces Closing Of Public Offering And Full Exercise Of Over-Allotment Option 12/17/2014 7:39:09 AM
Agios Pharmaceuticals (AGIO) Announces Pricing Of $220 Million Public Offering Of Common Stock 12/11/2014 7:30:29 AM
Agios Pharmaceuticals (AGIO) Announces Proposed Offering Of Common Stock 12/10/2014 6:57:44 AM
Agios Pharmaceuticals (AGIO) Appoints Kaye Foster-Cheek To Its Board Of Directors 12/10/2014 6:56:50 AM
Agios Pharmaceuticals (AGIO) Reports Positive Phase 1 Data In Healthy Volunteers For AG-348, A First-In-Class Investigational Medicine That Targets The Underlying Cause Of Pyruvate Kinase (PK) Deficiency 12/9/2014 10:17:24 AM
Agios Pharmaceuticals (AGIO) Announces Celgene (CELG) Decision To Extend Discovery Phase Of Global Strategic Collaboration To April 2016 12/8/2014 8:34:12 AM
Agios Pharmaceuticals (AGIO) Announces New Data From Ongoing Phase 1 Trial Of AG-221 Showing Robust Clinical Activity In Patients With Advanced Hematologic Malignancies 12/8/2014 7:31:58 AM
Agios Pharmaceuticals (AGIO) Announces Early Phase 1 Data Showing Clinical Activity Of AG-120 As A Single Agent In Advanced Acute Myeloid Leukemia (AML) 11/18/2014 4:43:48 PM
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014 12:58:54 PM
Agios Pharmaceuticals (AGIO) Reports Third Quarter 2014 Financial Results 11/7/2014 8:47:52 AM
12345678910
//-->